Nelson M. Sims joins Aastrom Biosciences' Board of Directors
Advertisement
Aastrom Biosciences, Inc. (Nasdaq: ASTM) announced today that Nelson M. Sims has been elected to the Company's Board of Directors. He will serve as a Class III Director whose initial term expires at the 2006 Annual Meeting of Shareholders.
Mr. Sims joins Aastrom's Board with over 30 years of pharmaceutical industry experience. Most recently Mr. Sims was the President and Chief Executive Officer of Novavax, Inc., an international health and life science company. Prior to this, Mr. Sims held several senior executive management positions with Eli Lilly and Company until his retirement in 2001. During his 28 year tenure at Eli Lilly, Mr. Sims' positions included President of Eli Lilly Canada, Inc., Executive Director of Alliance Management, Vice President of Hybritech, Inc. and other assignments in sales and marketing management and business development. In his last position with Eli Lilly, Mr. Sims lead the Alliance Management initiative responsible for "Best in Class" partnering capabilities for research and development, commercial and development alliances.
Mr. Sims received a Bachelor of Science degree in Pharmacy at Southwestern Oklahoma State University, and completed the Tuck Executive Program at the Amos Tuck School of Business at Dartmouth College. He also serves on the board of MDS, Inc.
Most read news
Other news from the department people

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents

Bacteria and sand engineered into living concrete
Stem cell transplantation: Chance of survival increases with number of procedures - IQWiG examines evidence for minimum volumes

Study reveals the structure of the 2nd human cannabinoid receptor
Evogene Participates In Israeli Agbio Consortium - BIOTOV MAGNET Consortium to focus on improved Nutritional Qualities for Fruits and Vegetable

Revealing the secrets of cell competition - Which features distinguish “winner” from “loser” cells
BioInvent signs deal with Bayer HealthCare for the discovery and development of therapeutic antibodies

Avoiding animal testing with vegan antibodies - Spin-off project "Ymolution" launched

A matter of timing - To bloom or not to bloom? Max Planck researchers discover how flowering time is affected by temperature

Peanut Allergy Prevention: Researchers Uncover Groundbreaking Solution
List_of_subjects_in_Gray's_Anatomy:_VI._The_Arteries
